Jose Melendez InspectorProfile

This FDA InspectorProfile is a report of relevant audit-related information on Jose Melendez, a U.S. Food & Drug Administration investigator who primarily conducts inspections in the area of Human Drugs.

Product Description

This InspectorProfile report is updated through Dec 2022 and lists Jose Melendez's inspections in 32 countries: United States, Mexico, Argentina, Italy, South Africa, Canada, United Kingdom, Ireland, Germany, Denmark, China, Brazil, Japan, Thailand, Belgium, Portugal, Spain, Czech Republic, Finland, India, Romania, New Zealand, Australia, Malta, Trinidad & Tobago, Dominican Republic (the), France, Hong Kong SAR, Malaysia, Singapore, Korea (the Republic of), and Switzerland.

FDA audits are stressful. Whether you are issued a 483 depends largely on your compliance with GxP and predicate rules; but it can also depend on the Agency's current focus and the tendencies of your specific investigator(s). FDAzilla has curated Jose Melendez's inspection information so that you can mitigate investigator-related risks.

Example Report

Below is an example of what a FDAzilla InspectorProfile report contains; This is not the actual data for Jose Melendez.

Product details

• Jose Melendez's metrics:
  • 483 issue rate, total inspections, total 483s
  • Most common citations (based on CFR), CFR description, and citation frequency
  • Total inspections, total 483s
  • Longest / shortest inspection in duration - all time, last year
  • Total warning letters
• Inspection details for each inspection (since 2000) Jose Melendez has conducted including:
  • Company, site inspected, duration of inspection
  • Co-inspectors Jose Cayuela, Anitha Govada, Dongping Dai, Kellia Hicks, Krishna Ghosh, year of last co-inspection, number of co-inspections
  • If a 483 issued, and whether or not it resulted in a warning letter.

Note: The EIR and 483 documents are sold separately.